Development
Biodesix, Inc.
BDSX
$0.3029
$0.02117.49%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 20.32% | -8.48% | -17.59% | -32.40% | -51.64% |
| Total Depreciation and Amortization | -5.77% | 15.73% | 49.75% | 71.30% | 83.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.31% | 7.29% | 66.20% | 222.03% | 164.76% |
| Change in Net Operating Assets | 360.22% | 462.09% | 1,163.73% | -76.77% | -194.62% |
| Cash from Operations | 49.15% | 47.86% | 28.64% | -31.88% | -59.35% |
| Capital Expenditure | -594.94% | -1,052.00% | -705.76% | -425.87% | -47.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.41% | 36.90% | 45.45% | 49.13% | 22.88% |
| Cash from Investing | -552.57% | -907.68% | -603.11% | -356.90% | -38.75% |
| Total Debt Issued | -77.83% | 98.65% | 98.65% | 24,761.33% | 49.95% |
| Total Debt Repaid | 99.83% | 5.75% | -11.15% | -42.86% | 37.03% |
| Issuance of Common Stock | -52.03% | 65.72% | 33.29% | 211.62% | 244.97% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 45.54% | -21.73% | -39.08% | -186.33% | -2,047.10% |
| Cash from Financing | -50.53% | 288.67% | 127.18% | 1,009.01% | 4,565.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -261.94% | 114.25% | 59.74% | 122.74% | 135.16% |